INSYS Therapeutics to Present at J.P. Morgan Healthcare Conference
January 03 2018 - 9:00AM
INSYS Therapeutics, Inc. (NASDAQ:INSY), announced today that Saeed
Motahari, president and chief executive officer, and Andrew Long,
chief financial officer, will present at the 36th annual J.P.
Morgan Healthcare Conference as follows:
Date: |
|
|
|
Thursday, Jan. 11,
2018 |
Time: |
|
|
|
7:30 a.m. Pacific
Standard Time |
Location: |
|
|
|
San Francisco – Westin
St. Francis Hotel |
The presentation will be webcast live at the aforementioned
time, and archived for 30 days thereafter, via the Investors
section of company’s website at https://www.insysrx.com/, under
Presentations & Events. The presentation slides will be
available during the conference, accessible at the same
webpage.
In addition to making a presentation, management will also
provide an overview of the company’s business in one-on-one
meetings with investors who are registered to attend the
conference.
About INSYS INSYS Therapeutics is a specialty
pharmaceutical company that develops and commercializes innovative
drugs and novel drug delivery systems of therapeutic molecules that
improve patients’ quality of life. Using proprietary spray
technology and capabilities to develop pharmaceutical cannabinoids,
INSYS is developing a pipeline of products intended to address
unmet medical needs and the clinical shortcomings of existing
commercial products.
|
|
|
CONTACT: |
Corporate
Communications |
Investor
Relations |
|
Joe McGrath |
Jackie Marcus or Chris
Hodges |
|
INSYS Therapeutics |
Alpha IR Group |
|
480-500-3101 |
312-445-2870 |
|
jmcgrath@insysrx.com |
INSY@alpha-ir.com |
INSYS THERAPEUTICS, INC. (NASDAQ:INSY)
Historical Stock Chart
From Mar 2024 to Apr 2024
INSYS THERAPEUTICS, INC. (NASDAQ:INSY)
Historical Stock Chart
From Apr 2023 to Apr 2024